Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Angiotensin II Versus Noradrenaline Trial for Hypotension Management to Reduce Cardiac-surgery Associated Acute Kidney Injury (PAN-AKI)

NCT06615102 is registered in ClinicalTrials.gov with Universität Münster as lead sponsor.

NCT NCT06615102
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06615102 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Angiotensin II Versus Noradrenaline Trial for Hypotension Management to Reduce Cardiac-surgery Associated Acute Kidney Injury (PAN-AKI)
Lead sponsor
Universität Münster
Phase
Phase 3
Overall status
Recruiting
Start date
March 31, 2025
Completion date
April 30, 2027
Enrollment
1,022 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac surgery, vasoplegia